Lecture
Mediaspace scheduled maintenance: Aug 25, 2026 07:00 - 12:00 AM. During this time, videos will be temporarily unavailable. Check status updates.
This lecture covers the selection of viral vectors for gene therapy, focusing on factors such as genomic integration, cell types transduced, transcript length, vector design, viral genome, and immune reactions. Specific examples are provided, including the use of adeno-associated virus (AAV) vectors for spinal muscular atrophy type 1 (SMA1) therapy and different routes of administration for AAV vectors in the central nervous system.